23/10/2026
We are excited to share two important updates.
First, following a scheduled safety review, the clinical trial's Safety Review Committee authorized the continued enrollment and treatment of the remaining participants in the first cohort.
Second, we are happy to announce the activation of our second clinical trial site at the University of California San Francisco (UCSF) Benioff Children's Hospital in Oakland, California. Both clinical trial sites are currently actively enrolling candidate participants, and the trial enrollment is progressing as planned.
Official Resources:
▪️foxg1genetherapy.org - dedicated site for FRF-001 FAQs
▪️clinicaltrials.gov - official trial listing and study information
▪️[email protected] - submit all questions to the clinical team
*Please note: Foundation leadership is unable to respond to individual questions about FRF-001 directly.